BMNP Calc Phos (calcarea phosphorica) NDC 82969-1202

NDC codes

FDA NDC Directory

Product NDC (as listed)82969-1202Labeler and product segments. Claims need a package NDC.

Product NDC at billing width82969-1202Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
82969-1202-1	82969120201	25 g in 1 BOTTLE, GLASS (82969-1202-1)Marketed from Jun 1, 2026
82969-1202-2	82969120202	8 g in 1 BOTTLE, GLASS (82969-1202-2)Marketed from Jun 1, 2026

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): BMNP Calc Phos
Generic name (nonproprietary): calcarea phosphorica
Active ingredients: Tribasic calcium phosphate — 6 [hp_X]/g
Dosage form: Globule
Route: Oral
Labeler: Total Operations Management LLC DBA:Bestmade Natural Products Micro
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Jun 1, 2026
Listing expires: Dec 31, 2027
Identifiers: Product ID 82969-1202_5a1d6586-77cf-803a-e063-6394a90ad250SPL ID 5a1d6586-77cf-803a-e063-6394a90ad250SPL set ID 5a1cff3f-c18e-7869-e063-6294a90a8226UNII 91D9GV0Z28

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N482969120201 followed by a unit qualifier and the quantity

Package 82969-1202-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 28, 2026.

Indications (excerpt from the label)

Helps temporarily relieve: feelings of exhaustion during recovery from illness; discomfort associated with growth-related issues, such as delayed tooth development and recovery from broken bones; and discomfort associated with low iron and thinness.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)